Garenoxacin API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Garenoxacin API Manufacturer in India

Garenoxacin API is a synthetic quinolone antibacterial agent belonging to the des-fluoroquinolone class. It is also known by the development code T-3811 and is structurally related to the fluoroquinolone class, but lacks the conventional fluorine substituent at the C-6 position. Garenoxacin exhibits antibacterial activity against a broad range of Gram-positive and Gram-negative bacteria.

Garenoxacin has the molecular formula C₂₃H₂₀F₂N₂O₄, molecular weight 426.41 g/mol, and CAS Registry Number 194804-75-6. The molecule contains one defined stereocenter and is identified as the (R)-configuration.

For pharmaceutical use, Garenoxacin Mesylate is an important salt form. Garenoxacin mesylate has CAS 223652-90-2 and a molecular weight of 540.5 g/mol for the mesylate monohydrate.

Chemical and Pharmaceutical Profile

PropertyValue
API NameGarenoxacin
CAS Number194804-75-6
Development CodeT-3811 / BMS-284756
Molecular FormulaC₂₃H₂₀F₂N₂O₄
Molecular Weight426.41 g/mol
Chemical ClassDes-fluoroquinolone / Quinolone
Pharmacological ClassQuinolone Antibacterial
Stereochemistry(R)
Defined Stereocenters1
AppearanceSolid
Mesylate Salt CAS223652-90-2
Mesylate Monohydrate MW540.5 g/mol

The free compound and mesylate forms must be kept separate in your CMS because their CAS numbers and molecular weights are different.

Mechanism of Action

Garenoxacin is a quinolone antibacterial that acts primarily by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes required for bacterial DNA replication, transcription and chromosome maintenance.

Inhibition of these essential enzymes interferes with bacterial DNA processing and ultimately leads to bacterial cell death.

Pharmaceutical Applications

Garenoxacin has been investigated and used as an antibacterial agent for the treatment of bacterial infections involving susceptible microorganisms. It has activity against both Gram-positive and Gram-negative bacteria.

The API is relevant to:

  • Antibacterial drug development
  • Oral pharmaceutical formulation
  • Quinoline/quinolone research
  • Analytical method development
  • Impurity profiling
  • Stability studies
  • Quality-control testing
  • Pharmaceutical research and development

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Heavy Metals NMT 20 ppm
pH (1% Solution) 5.5 – 6.5
Individual Impurity NMT 0.5%
Melting Point 226–227°C
Solubility Slightly soluble in DMF, DMSO and methanol when heated
Get Bulk Quote via WhatsApp